Navigation Links
PDI Reports 2012 Fourth Quarter and Year End Financial Results
Date:3/6/2013

preciation and amortization5445992,0342,665Stock compensation2712531,7911,936Asset impairment23,517-23,517-Facilities realignment706-706-Adjusted EBITDA$
,099$
(1,585)$
2,816$
(101)Conference CallAs previously announced, PDI will hold a conference call tomorrow, Thursday, March 7 to discuss financial and operational results for the fourth quarter and year ended December 31, 2012 as follows:

Time: 8:30 AM (ET)
Dial-in numbers: (866) 644-4654 (U.S. and Canada) or (706) 643-1203
Conference ID#: 98411955

Live webcast: www.pdi-inc.com, under "Investor Relations"

The teleconference replay will be available three hours after completion through March 11, 2013 at (800) 585-8367 (U.S. and Canada) or (404) 537-3406. The replay pass code is 98411955. The archived web cast will be available for one year.

About PDI, Inc. PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise. For more information, please visit the company's website at http://www.pdi-inc.com.

Forward-Looking StatementsThis press release contains forward-looking statements regarding future events and financial performance. These statements are based on current expectations and assumptions involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control. These statements also involve known and unknown risks,
'/>"/>

SOURCE PDI, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. MGC Diagnostics Corporation Reports 2013 First Fiscal Quarter Operating Results
2. Nephros Reports 2012 Fourth Quarter and Full Year Financial Results
3. ECRI Institute PSO Offers Key Reports on Health IT and Medication Safety for Patient Safety Awareness Week
4. Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
5. Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
6. IRIDEX Reports Record 2012 Fourth Quarter Results
7. Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
8. On-Demand Reports on Partnering Terms in Healthcare & Pharma Sectors: New Market Research at ReportsnReports.com
9. Isis Reports Financial Results and Highlights for 2012
10. NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results
11. Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 The American Association for Homecare (AAHomecare), along ... , announced today the filing of a lawsuit ... , asking that the scheduled July 1 expansion of ... (DME) be stopped because of serious licensing irregularities. ... (HHS) Secretary Kathleen Sebelius as the defendant. ...
(Date:6/19/2013)... 19, 2013 Amgen is pleased to announce the ... , Canada and Puerto ... Amgen Award for Science Teaching Excellence (AASTE). Now in its ... through 12th grade level who have an outstanding ability to ... With a long-standing commitment to science education, Amgen established the ...
(Date:6/19/2013)... 2013 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... England Journal of Medicine ( NEJM ) published ... investigational oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in ... lymphocytic lymphoma (SLL). Ibrutinib was shown to be safe ... even in patients who were at high-risk due to ...
Breaking Medicine Technology:AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 2Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6
... Texas and KOLN, Germany, June 8, 2011 Luminex ... der Stadt Koln, Institute of Pathology and Institute for ... Pathogen Panel (GPP) is being used successfully as a ... suspected of having an E. coli infection.  This includes ...
... Company (NYSE: LLY ) today announced that ... California ruled in Lilly,s favor, vacating a temporary restraining ... a preliminary injunction that sought to impose restrictions on ... recently filed litigation involving the two companies, diabetes collaboration ...
Cached Medicine Technology:Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis 2Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis 3Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis 4U.S. District Court Rules in Favor of Lilly in Amylin Litigation 2
(Date:6/19/2013)... PrettySkin4Less announces it is stocking up with ... top skin care manufacturer EMINENCE to meet customer demands. ... and active organic ingredients to promote actual change rather ... products offer. For this reason it’s not hard to ... like products that do what they say they will ...
(Date:6/19/2013)... 2013 Strict rules for ... Orriant is launching a new tool to help ... with regulations. New HHS regulations will soon ... if their employer offers outcome-based, health-contingent, compliant wellness ... with these standards for nearly a decade. Orriant ...
(Date:6/19/2013)... New York, New York (PRWEB) June 19, 2013 ... involving pancreatitis and pancreatic cancer continue to mount in ... the U.S. Food & Drug Administration (FDA) recently held ... other diabetes drugs known as incretin mimetics. According ... may seek additional data from the makers of Januvia ...
(Date:6/19/2013)... In what is believed to be the largest follow-up ... hereditary dystonia a movement disorder that can cause ... report good success rates and lasting benefits. , Michele ... at Cedars-Sinai Medical Center,s Department of Neurology, and Ron ... at Beth Israel Deaconess Medical Center in Boston, published ...
(Date:6/19/2013)... disparities between minority and white clients in success ... these disparities vary widely from state to state. ... states there,s something amiss," says Stephan Arndt, Ph.D., ... strong racial and ethnic disparities for people in ... successfully, and those disparities are something we need ...
Breaking Medicine News(10 mins):Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3
... , TUESDAY, Dec. 14 (HealthDay News) -- ... genetic mutations associated with adrenal gland tumors by identifying ... affect the adrenal gland, which is located above the ... can also be cancerous -- cause the adrenal gland ...
... R.I. [Brown University] Brown University sociologists have ... about risky sexual behavior among Ethiopian teenagers and ... Simple, portable, low-cost, and low-tech, the group,s new ... and confidentially during face-to-face interviews. Professors of sociology ...
... Dec. 14 (HealthDay News) -- Two reports from the U.S. ... is hitting young and older Americans across the economic,spectrum. ... and Prevention, released the reports on Tuesday. Looking at ... data from 1988 to 1994 and from 2005 to 2008, ...
... Dec. 14, 2010 Cancer Research Institute, Inc. (CRI), ... the science of tumor immunology and foster the discovery ... the Cancer Vaccine Acceleration Fund (CVAF), a new model ... with the Ludwig Institute for Cancer Research Ltd (LICR) ...
... French . , MONTREAL, December 14, 2010 The ... learn to recognize the sound of their parents, voice and the ... parents and newborns admitted to the intensive care unit can be ... , Jan Lariviere, a nurse in the neonatal clinic and the ...
... Gardner HealthDay Reporter , TUESDAY, Dec. 14 (HealthDay ... the most from health-care reform, a new report shows. ... the elimination of restrictions on people with preexisting conditions, while ... subsidized coverage through health insurance exchanges -- are slated for ...
Cached Medicine News:Health News:New survey device gets better information on teenage sexual behavior 2Health News:New survey device gets better information on teenage sexual behavior 3Health News:Obesity Rising Across All Income Levels: CDC 2Health News:Cancer Research Institute launches Cancer Vaccine Acceleration Fund 2Health News:Cancer Research Institute launches Cancer Vaccine Acceleration Fund 3Health News:Cancer Research Institute launches Cancer Vaccine Acceleration Fund 4Health News:Once upon a time in the Intensive Care Unit ... 2Health News:Report Finds Baby Boomers to Gain Most From Health Care Reform 2Health News:Report Finds Baby Boomers to Gain Most From Health Care Reform 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: